| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 10.565 | 2.785 | 12.177 | 4.826 | 4.515 | 2.731 | 6.358 |
| Total Income - EUR | - | - | - | 26.527 | 45.552 | 19.206 | 5.480 | 4.515 | 5.905 | 6.358 |
| Total Expenses - EUR | - | - | - | 16.695 | 17.341 | 4.804 | 6.604 | 5.362 | 5.777 | 4.153 |
| Gross Profit/Loss - EUR | - | - | - | 9.832 | 28.211 | 14.402 | -1.124 | -847 | 128 | 2.205 |
| Net Profit/Loss - EUR | - | - | - | 9.240 | 26.845 | 13.878 | -1.267 | -976 | 99 | 1.859 |
| Employees | - | - | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Xtae Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 16.807 | 12.859 | 39.342 | 33.746 | 29.113 | 23.900 | 20.026 |
| Current Assets | - | - | - | 5.551 | 6.610 | 21.450 | 15.950 | 13.400 | 14.944 | 11.167 |
| Inventories | - | - | - | 31 | 31 | 30 | 29 | 29 | 0 | 0 |
| Receivables | - | - | - | 5.308 | 5.205 | 10.707 | 10.565 | 10.577 | 11.888 | 8.546 |
| Cash | - | - | - | 212 | 1.374 | 10.713 | 5.356 | 2.793 | 3.056 | 2.620 |
| Shareholders Funds | - | - | - | 11.951 | 38.564 | 46.052 | 42.700 | 36.520 | 16.292 | 2.006 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 10.408 | -19.095 | 14.739 | 6.996 | 5.993 | 22.552 | 29.187 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Xtae Med Srl